Evidence map›Paper›PMID 25832668›Full record

ArticleNeurology2015

Impairments and comorbidities of polyneuropathy revealed by population-based analyses.

E Matthew Hoffman, Nathan P Staff, Jared M Robb, Jennifer L St Sauver, Peter J Dyck, Christopher J Klein

Open access · bronzeAbstract read
In one paragraph

Article in Neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 4 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Review
  10. Charcot-Marie-Tooth disease and related neuropathies.Nature reviews. Disease primers · 2026
    Review
  11. The success-failure inversion in modern medicine.Frontiers in public health · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E Matthew HoffmanFrom the Department of Neurology (E.M.H., N.P.S., P.J.D., C.J.K.), Divisions of Biomedical Statistics and Informatics (J.M.R.) and Epidemiology (J.L.S.), and Division of Medical Genetics and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN.
Nathan P StaffFrom the Department of Neurology (E.M.H., N.P.S., P.J.D., C.J.K.), Divisions of Biomedical Statistics and Informatics (J.M.R.) and Epidemiology (J.L.S.), and Division of Medical Genetics and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN.
Jared M RobbFrom the Department of Neurology (E.M.H., N.P.S., P.J.D., C.J.K.), Divisions of Biomedical Statistics and Informatics (J.M.R.) and Epidemiology (J.L.S.), and Division of Medical Genetics and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN.
Jennifer L St SauverFrom the Department of Neurology (E.M.H., N.P.S., P.J.D., C.J.K.), Divisions of Biomedical Statistics and Informatics (J.M.R.) and Epidemiology (J.L.S.), and Division of Medical Genetics and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN.
Peter J DyckFrom the Department of Neurology (E.M.H., N.P.S., P.J.D., C.J.K.), Divisions of Biomedical Statistics and Informatics (J.M.R.) and Epidemiology (J.L.S.), and Division of Medical Genetics and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN.
Christopher J KleinFrom the Department of Neurology (E.M.H., N.P.S., P.J.D., C.J.K.), Divisions of Biomedical Statistics and Informatics (J.M.R.) and Epidemiology (J.L.S.), and Division of Medical Genetics and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN. klein.christopher@mayo.edu.
Mayo Clinic · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Identification of Genetic Causes of Hereditary Sensory and Autonomic NeuropathiesK08NS065007 · NINDS · MAYO CLINIC ROCHESTER · PI KLEIN, CHRISTOPHER · 2009 to 2013
$855k
Mechanisms of Bortezomib-induced Peripheral NeuropathyK08CA169443 · NCI · MAYO CLINIC ROCHESTER · PI STAFF, NATHAN P · 2012 to 2016
$722k
NCI NIH HHS K08 CA169443NCI NIH HHS K08 CA169443-02NCRR NIH HHS UL1 RR000135NIA NIH HHS R01 AG034676NINDS NIH HHS K08 NS065007
6 · The paper itself

Abstract

objectiveTo quantify polyneuropathy impairments and comorbidities utilizing the Rochester Epidemiology Project (2010 census = 148,201).

methodsICD-9-CM coding identified polyneuropathy cases (2006-2010) and their 5:1 age- and sex-matched controls. Mortality and impairments were evaluated while identifying and adjusting for Charlson Index comorbidities.

resultsOverall prevalence of polyneuropathy was 1.66%, and markedly rose to 6.6% in persons older than 60 years. Cases (n = 2,892) had more comorbidities than controls (n = 14,435) with higher median Charlson Index (6 vs 3, p < 0.001). Diabetes with end-organ disease represented the largest increased comorbidity in cases compared with controls (46.8% vs 6.5%). Diabetic polyneuropathy was the most common specific subtype (38.2%). Miscoded idiopathic cases and false-negative controls also commonly had diabetic polyneuropathy. Median modified Rankin Scale score was considerably higher for cases than controls (4 vs 1, p < 0.001). Multiple comorbidities were found associated with polyneuropathy after adjusting for diabetes co-occurrence, including pulmonary disease, dementia, and others. Polyneuropathy was an independent contributor to multiple functional impairments including difficulty walking (odds ratio [OR] = 1.9), climbing stairs (OR = 2.0), using an assistive device (OR = 2.0), fall tendency (OR = 2.4), work disability (OR = 4.2), lower limb amputations (OR = 3.9), and opioid use (OR = 2.7). Prevalent cases had a younger median age at death than controls (80 vs 86 years, p < 0.001), and incident cases had a 6-month shorter survival.

conclusionsPolyneuropathies have notable neurologic impairments beyond their identified multiple comorbidities. Life expectancy is shortened. Diabetic polyneuropathy is underidentified. The quantified extent of the disease burden and refined comorbidity associations emphasize that greater research efforts and health care initiatives are needed.

Indexed as

ComorbidityAdolescentAdultAgedAged, 80 and overCase-Control StudiesChildChild, PreschoolDiabetic NeuropathiesFemaleHumansInfantMaleMiddle AgedMinnesotaPolyneuropathies

Identifiers

PMID25832668
PMCPMC4409579
OpenAlexW1994233249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.